Limiting the Spread of Multidrug-Resistant Bacteria in Low-to-Middle-Income Countries: One Size Does Not Fit All

Rindala Saliba1,2,3, Jean-Ralph Zahar4, Georges Dabar3,5

  • 1Clinical Microbiology Department, Hotel-Dieu de France University Hospital, Beirut 1100, Lebanon.

Insights

Multidrug-resistant organism (MDRO) spread increases costs and mortality. Low-cost strategies like hand hygiene and antimicrobial stewardship are effective for MDRO control in resource-limited settings.

Area of Science:

  • Infectious Diseases
  • Healthcare Management
  • Public Health

Background:

  • Multidrug-resistant organisms (MDRO) pose significant threats, increasing healthcare costs, morbidity, and mortality.
  • Risk factors for MDRO spread are categorized as bacterial, host-related, organizational, and epidemiological.
  • International guidelines recommend control measures including surveillance, isolation, enhanced hygiene, and antimicrobial stewardship.

Purpose of the Study:

  • To evaluate the real risks of MDRO dissemination.
  • To propose an alternative policy for MDRO control tailored to low- and middle-income countries (LMICs).

Main Methods:

  • Literature review to assess MDRO dissemination risks.
  • Analysis of existing international control policies and their applicability in LMICs.

Main Results:

  • High compliance with hand hygiene and antimicrobial stewardship significantly reduces MDRO transmission risk.
  • Costly isolation protocols and additional contact precautions may not be essential for effective MDRO control.

Conclusions:

  • LMICs can effectively control MDRO spread by prioritizing low-cost interventions like hand hygiene and antimicrobial stewardship.
  • An alternative policy focusing on these core measures is more feasible and sustainable for LMICs than implementing comprehensive international protocols.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
68
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.7K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.4K
Methods for Controlling Microbial Growth01:29

Methods for Controlling Microbial Growth

Microbial growth control refers to various methods employed to inhibit, reduce, or eliminate microorganisms to ensure safety and hygiene across different settings. These methods are categorized based on the target environment and the level of microbial control required.Biocides are versatile agents designed to control microorganisms by either inhibiting their growth or outright killing them. These agents work through various physical, chemical, mechanical, or biological mechanisms. The...
206
Antibiotic Selection00:57

Antibiotic Selection

Overview
54.9K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
225